XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.1
FAIR VALUE
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
FAIR VALUE

4. FAIR VALUE

 

In accordance with ASC 820, Fair Value Measurements and Disclosures, financial instruments were measured at fair value using a three-level hierarchy which maximizes use of observable inputs and minimizes use of unobservable inputs:

 

  Level 1: Observable inputs such as quoted prices in active markets for identical instruments.
     
  Level 2: Quoted prices for similar instruments that are directly or indirectly observable in the market.
     
  Level 3: Significant unobservable inputs supported by little or no market activity. Financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, for which determination of fair value requires significant judgment or estimation.

 

Financial instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. There were no transfers within the hierarchy for any of the periods presented.

 

The following table sets forth the fair value of the Company’s financial assets and liabilities measured on a recurring basis by level within the fair value hierarchy (in thousands):

 

   Level 1   Level 2   Level 3   Total 
   December 31, 2021 
   Level 1   Level 2   Level 3   Total 
Liabilities                
Common stock warrant liability  $   $   $6,844   $6,844 
Total  $   $   $6,844   $6,844 

 

   Level 1   Level 2   Level 3   Total 
   December 31, 2020 
   Level 1   Level 2   Level 3   Total 
Liabilities                
Common stock warrant liability  $   $   $5,975   $5,975 
Total  $   $   $5,975   $5,975 

 

The Company assesses its long-lived assets, including property, plant, and equipment, ROU assets, intangible assets, and goodwill, at fair value on a non-recurring basis. The Company reviews the carrying amounts of such assets when events indicate that their carrying amounts may not be recoverable. Any resulting impairment would require that the asset be recorded at its fair value. During the year ended December 31, 2021, the Company recognized an impairment charge of $0.6 million related to definite-lived intangible assets and goodwill and $0.4 million related to property and equipment. As of each measurement date, the fair value of goodwill, intangibles and property and equipment was determined utilizing Level 3 inputs. Fair values of goodwill and intangibles and property and equipment was determined based on a market approach and income approach, respectively. See Note 8 and Note 15 for additional details.

 

 

The following table presents the change in fair value of the liability classified common stock warrants for the year ended December 31, 2021 (in thousands):

 

   Fair Value at December 31, 2020   Initial Fair Value at Issuance   (Gain) Loss Upon Change in Fair Value   Liability Reduction Due to Exercises   Fair Value at December 31, 2021 
Warrant liabilities                         
February 14, 2020 issuance  $328   $   $(37)  $   $291 
December 23, 2020 issuance   5,647        3,556    (8,964)   239 
January 14, 2021 issuance       8,629    (5,284)       3,345 
January 25, 2021 issuance(1)(1)      6,199    (3,230)       2,969 
Total
  $5,975   $14,828   $

(4,995

)  $(8,964)  $6,844 

 

  (1) Concurrent with the issuance of the January 25, 2021 warrants, upon the exercise of the December 23, 2020 warrants, an inducement loss of $5.2 million was recorded as the fair value of the initial warrant liability for the new warrants of $6.2 million exceeded the gross proceeds received upon sale of the new warrants of approximately $1.0 million

 

The following table presents the change in fair value of the liability classified common stock warrants for the year ended December 31, 2020 (in thousands):

 

   Initial Fair Value at Issuance   Liability Reduction Due to Exercises   (Gain) Loss Upon Change in Fair Value   Fair Value at December 31, 2020 
Warrant liabilities                    
February 14, 2020 issuance  $11,677   $(8,265)  $(3,084)  $328 
December 23, 2020 issuance   5,477        170    5,647 
Total  $17,154   $(8,265)  $(2,914)  $5,975 

 

 

The Company uses the Monte Carlo valuation model to determine the fair value of the liability classified warrants issued during 2021 and 2020. Input assumptions for these freestanding instruments are as follows:

 

    For the Year Ended December 31, 2021  
Stock price  $0.59 - 1.21 
Exercise price  $0.10 - 1.38 
Risk-free rate   0.42 - 1.27 % 
Volatility   99.0103.9 % 
Remaining term (years)   4.0 - 5.9 

 

    For the Year Ended December 31, 2020  
Stock price  $0.65 - 1.69 
Exercise price  $0.10 - 2.80 
Risk-free rate   0.36 - 1.51 % 
Volatility   93.4 99.7 % 
Remaining term (years)   5.0 - 7.0